Universitair Ziekenhuis Antwerpen
Universitair Ziekenhuis Antwerpen is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Randomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 (Proposed Nivolumab Biosimilar) Versus EU-/US-Opdivo in Subjects With Previously Untreated Advanced (Unresectable or Metastatic) Melanoma (LEON Study)
Sponsor Mabxience Research S.L.
- Start (EU)
- Latest update
- Estimated end
PROlonged versus Single dose in PEnicillin oral Challenge Testing double-blind parallel randomized placebo cOntrolled tRial – PROSPECTOR-2 Study
Sponsor Gentofte Hospital
- Start (EU)
- Latest update
- Estimated end
Efficacy and safety of a 4 year pubertal therapy with growth hormone (Omnitrope) or growth hormone and an aromatase inhibitor (Letrozole) in boys with a short predicted height.
Sponsor Universitair Ziekenhuis Antwerpen
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Universitair Ziekenhuis Antwerpen?
The 2026-10-09 snapshot links Universitair Ziekenhuis Antwerpen to 3 distinct CTIS trials. Recorded services include Clinical monitoring, Laboratory services, PD-L1 testing, study department. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Universitair Ziekenhuis Antwerpen?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Universitair Ziekenhuis Antwerpen conducted?
The linked trials record locations in 9 countries, including Belgium, Denmark, Spain, Greece, Italy. These are trial locations, not confirmed office locations or countries where Universitair Ziekenhuis Antwerpen delivered services.
What can this page tell me about Universitair Ziekenhuis Antwerpen's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Universitair Ziekenhuis Antwerpen. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Universitair Ziekenhuis Antwerpen